Previously submitted to: JMIR Public Health and Surveillance (no longer under consideration since Oct 06, 2022)
Date Submitted: Jan 7, 2022
Open Peer Review Period: Dec 24, 2021 - Jan 7, 2022
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
COVID-19 patient cohort identification during the SARS-CoV-2 outbreak through a tertiary hospital Electronic Health Record alert system
ABSTRACT
Background:
On 11th March 2020, the World Health Organization declared a pandemic caused by the coronavirus with 118.629 identified cases and 4.292 confirmed deaths. Up to date, 252 million cases and 5 million deaths have been identified as caused by COVID-19. An epidemic situation is characterized by an overload of patients suffering a particular clinical condition and needing acute medical attention in a short period. Usually, the pathogen n causing the epidemic is either new or emergent, and the knowledge a priori is limited. Information is crucial for public health authorities to establish policies to prevent transmission. Thus, the cycle of knowledge acquisition must be efficient and as short as possible. An interdisciplinary team adapted the electronic health record alert systems for real-time data tool collection for clinical characterization and epidemiological surveillance. This system has been working from the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first outbreak up to date
Objective:
To share the experience of handling COVID-19 and non-COVID-19 patients' circuits through an Electronic Health Record (EHR) alert system during the pandemic. This system allowed the creation of a COVID-19 hospitalized patient cohort, with implications in the hospital circuit management, patients risk stratification and secondary use for research projects in a period of high uncertainty. Additionally, its integration as an epidemiological surveillance tool favored the submission of updated information to public health authorities.
Methods:
Almost 30,000 alerts related to COVID-19 were activated in the EHR. Overall, the most frequent were “COVID-19 ruled out” (N = 12,438) followed by “COVID-19 Confirmed Case” (N = 8,999). Up to 13,106 patients (65.7%) were labeled with just one alert during their in-patient stay, while 6,857 (34.3%) received two or more labels. For the alert sequences, 96% were considered logical sequences, 3,1% as low-quality logic sequences, and less than 1% aberrant sequences. Although some temporal variations, all periods had a high rate of logical sequences achieving more than 95%. Preventive medicine professionals activated most COVID-19 alerts and acted as auditors for data quality. When possible, automatic alerts were in place, which became the most frequent.
Results:
Almost 30,000 alerts related to COVID-19 were activated in the EHR. Overall, the most frequent were “COVID-19 ruled out” (N = 12,438) followed by “COVID-19 Confirmed Case” (N = 8,999). Up to 13,106 patients (65.7%) were labeled with just one alert during their in-patient stay, while 6,857 (34.3%) received two or more labels. For the alert sequences, 96% were considered logical sequences, 3,1% as low-quality logic sequences, and less than 1% aberrant sequences. Although some temporal variations, all periods had a high rate of logical sequences achieving more than 95%. Preventive medicine professionals activated most COVID-19 alerts and acted as auditors for data quality. When possible, automatic alerts were in place, which became the most frequent.
Conclusions:
The EHR integrated system favored in-hospital management of patients during the COVID-19 pandemic. It was helpful for both the institution and the health system, representing an example of interlevel integration. The performance was adequate and robust, with insights at different levels: infection control, patient safety, research, and pandemic response. Preventive Medicine teams should maximize EHR solutions for epidemiological surveillance. Clinical Trial: Not required.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.